Cosmos Health Inc.: Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories

CHICAGO, IL / ACCESSWIRE / March 7, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals

Related Keywords

Illinois ,United States ,Athens ,Attikír ,Greece ,United Kingdom ,Chicago ,Ukraine ,America ,Greek ,Dennis Riedl ,Kosta Kanaroglou ,Greg Siokas ,Ben Shamsian ,Cana Laboratorie ,Company Nasdaq ,Exchange Commission On ,Cosmos Health Inc View ,Cosmos Health Inc ,Nasdaq ,Company Form ,Unilever ,Astrazeneca ,Lytham Partners ,Securities Exchange ,European Medicines Agency ,Medtronic ,Nestle ,Cosmos Health ,Pharmaceutical Laboratories ,Binding Letter ,Stock Purchase Agreement ,Chief Executive Officer ,Cana Laboratories ,Fast Moving Consumer Goods ,European Good Manufacturing Practices ,Exchange Commission ,Securities Act ,Securities Exchange Act ,Relations Contact ,Cosmos ,Health ,Centers ,Material ,Efinitive ,Agreement ,Adana ,Laboratories ,